Depression News

1. Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

   A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

2. Eating blueberries every day may have a surprising effect on your mood

   Eating blueberries every day could have surprising effects on mood, according to a small study that found greater reductions in depressive symptoms among older adults who consumed the fruit for three months. Researchers also detected changes in gut microbial enzymes, suggesting a possible gut-brain connection, although the mood benefits were not statistically significant compared with a placebo.

3. Scientists uncover 3 key brain pathways linked to lasting depression relief

   Researchers have uncovered three brain pathways linked to lasting improvements in people receiving deep brain stimulation for severe, treatment-resistant depression. They also discovered that patients who failed to improve after two years shared a striking pattern: insufficient stimulation of a crucial brain connection. The findings suggest that millimeters in electrode placement could make a major difference in treatment outcomes.

4. Scientists created a tiny device that can control your nerves to treat chronic pain

   Scientists have developed a tiny, injectable device that can control nerve activity without surgery, batteries, or wires, potentially transforming treatment for chronic pain and movement disorders. Powered wirelessly from outside the body, the seed-sized technology has shown promising results in early testing.

5. Children at risk for depression get “stuck” on sad faces

   Depression may change which emotional faces children notice most, but the pattern appears to depend on family history. Children at higher familial risk became increasingly focused on sad faces, while lower-risk children with rising symptoms paid less attention to happy ones.

6. Ozempic and Wegovy may have an unexpected mental health benefit

   Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization. Researchers think effects on inflammation and brain-related biological pathways could help stabilize mood, though other GLP-1 drugs did not show the same association.

7. Lab-grown mini brains may predict which Alzheimer’s treatments will work

   Miniature brain models grown from patients’ cells revealed striking differences in how Alzheimer’s-related tissue responds to an antidepressant. The organoids and the particles they release could eventually guide more personalized treatments and provide new clues for diagnosing the disease.

8. Scientists say creatine may help fight depression

   Creatine is best known as a muscle-building supplement, but scientists are now investigating whether it could also help treat depression by boosting the brain's energy supply. A new review examined five randomized clinical trials involving 238 participants and found mixed results. Two studies, both involving women with major depressive disorder, reported that adding creatine to standard treatment improved symptoms, while three others found no meaningful benefit.